Skip to main content
Premium Trial:

Request an Annual Quote

In Brief this Week: Sigma-Aldrich; Karolinska Institutet; Thermo Fisher Scientific; WaferGen Biosystems; DNA Genotek; Massachusetts Life Sciences Center

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sigma-Aldrich this week said that its board of directors has declared a quarterly cash dividend of $.16 per share. The dividend will be paid on June 15 to shareholders of record on June 1.

Swedish medical university Karolinska Institutet this week launched the LifeGene project, a collaboration among all medical faculties in Sweden and hosted by the institute. The project will gather information on the health and lifestyles of 500,000 Swedes, as well as blood and urine samples for later analysis. The objective is to improve diagnostics, treatments, and preventative recommendations.

Thermo Fisher Scientific this week gave notice that it intends to redeem all outstanding 6-1/8 percent senior subordinated notes due 2015 on July 1, 2010. As of May 3, $500 million in aggregate principal amount of the notes is outstanding.

WaferGen Biosystems said this week that it has signed on its tenth early access customer for its SmartChip Real-Time PCR System. The University of Texas Health Science Center at Houston joins the other early-access customers, including Ghent University, Stanford University, University of California at San Francisco, University of Pittsburgh, University of Southern California, the University of Texas Southwestern, two Japanese organizations, and an undisclosed US biotech company.

DNA Genotek announced that The Anthony Nolan Trust, the UK's largest bone marrow donor registry, has selected the firm's Oragene DNA collection device for a pilot project aimed at increasing donor recruitment.

The Massachusetts Life Sciences Center said that it is now accepting applications for its 2010 Life Sciences Tax Incentive Program. This is the second year of the program. Last year, it waraded $24.5 million in tax incentives to 26 life science companies, which committed to creating more than 800 jobs in the state. Applications are due by noon on July 2, and can be submitted via the organization's website.

State bonds totaling $62 million have been approved toward construction of a $126 million research facility for the Sanford Consortium for Regenerative Medicine by the California Infrastructure and Economic Development Bank. The consortium consists of Sanford-Burnham Medical Research Institute, Salk Institute for Biological Studies, The Scripps Research Institute, and University of California, San Diego.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.